TargImmune Therapeutics raised €16M in a funding round in Jul 2021. The company is based in Basel, Switzerland. Data as of 23 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
This is the company's only recorded round.
